Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. ... Factors such as cost, insurance coverage, and supply issues may affect your ability to get Zepbound.

Zepbound's prescription growth has surged ahead of Novo Nordisk's , opens new tab rival GLP-1 weight-loss drug Wegovy in recent months after struggles with supply issues in 2024.

Zepbound's prescription growth has surged ahead of Novo Nordisk's rival GLP-1 weight-loss drug Wegovy in recent months after struggles with supply issues in 2024.

As of July 1, CVS dropped Zepbound from preferred coverage for those covered by its pharmacy benefit manager, Caremark. Novo Nordisk A/S's Wegovy, a semiglutide injectable medicine, is now the ...